Patent Assignment
Reel/Frame 067998/0421
Change of Name
Recorded: 2024-07-16
Pages: 4
Assignor
HEPTARES THERAPEUTICS LIMITED
Executed: 2024-04-02
Assignee
NXERA PHARMA UK LIMITED
GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, CB21 6DG, UNITED KINGDOM
Covered Properties
(3)
Crystallisation and Purification of Glycopyrronium Bromide
Glycopyrronium Salts and Their Therapeutic Use
Use of Glycopyrrolate for Treating Tachycardia
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 25, 2008
From: BAXTER, ANDREW DOUGLAS; SINDEN, KENNETH WALTER; KLEINEBEKEL, STEFAN
To: SOSEI R&D LTD.
Reel/Frame 020854/0854 →
Assignment of Assignor's Interest
Nov 13, 2008
From: BAXTER, ANDREW DOUGLAS
To: SOSEI R&D LTD.
Reel/Frame 021826/0446 →
Assignment of Assignor's Interest
Feb 1, 2016
From: SNAPE, SUSAN; TANSLEY, ROBERT
To: SOSEI R&D LTD.
Reel/Frame 037635/0019 →
Assignment of Assignor's Interest
Dec 20, 2018
From: SOSEI R&D LTD.
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 047831/0220 →
Change of Address for Assignee
Jul 16, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 068384/0045 →
Change of Address for Assignee
Jul 16, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 068384/0493 →
Change of Address for Assignee
Jul 16, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 068384/0451 →